Investorkommunikasjon

Investorkommunikasjon

Investorkommunikasjon

>> Les mer om de siste nyhetene om Arctic Aurora LifeScience

>> Følg teamet på LinkedIn

>> For institusjonelle kunder, ta kontakt med vårt Business Development team

 

Produktspesialister Arctic Aurora LifeScience:

Norge
Vegard Gjølme
Partner, Institutional Sales
Arctic Asset Management 

Telefon:                +47 2101 3100
Direktetelefon:    +47 2101 3253
E-mail:                 vegard.gjoelme@arctic.com

Sverige
Anna Jakobson
CEFA, Institutional Sales
Arctic Asset Management / Spring Green Capital (Tied agent)

Telefon:    +46 8 446 86078
Mobil:       +46 720 509024
E-mail:     anna.jakobson@arctic.com

 

 

Arctic Aurora LifeScience is an equity fund investing in global biotechnology and pharmaceutical companies. The fund is run by former portfolio manager in the Swedish AP3 Fonder, Ulrica Bjerke, as well as Dr. Torbjørn Bjerke, both with 20 years of experience from the market. Arctic Aurora LifeScience was launched in May 2016 with both currency hedged and un-hedged share classes.

Past performance in Arctic Aurora LifeScience is no guarantee for future returns. Future returns depend on the market, fund manager skill, fund risk level, costs, among others. Performance in the fund may at times be negative and may for this fund vary considerably within periods.